In a recent study, Lisa D. Hobson-Webb and colleagues from Duke University, Durham, North Carolina, assessed the potential use of quantitative muscle ultrasonography and electrical impedance myography as biomarkers for late-onset Pompe disease progression. The authors highlight that these were reliable measures of muscle conduction and structure properties. Furthermore, patient-performed measurements at home were not significantly different from measurements obtained in clinic.